The Truth About the Pfizer Vaccine

November 14, 2020

Less Than 1% of People

Have Heard of This…

Have you ever heard of a "Shadow Blitz"?

If you haven't — you're not alone. In fact, less than 1% of people have heard about these special trading events that can make you thousands of dollars overnight...

Without having insider connections… without being an accredited investor… and without needing any trading experience.

To learn more about these trading loopholes — and cash in on their massive paydays — just click here.

Or here

These Sectors — Not Tech — Will Lead the Stock Market Higher

Today I wanted to share with you guys my appearance Monday on Cheddar, where I discussed the stock market's big pop on Pfizer's COVID-19 vaccine news.

Pfizer Inc. (NYSE: PFE) announced Monday positive early results from its Phase 3 coronavirus vaccine trials, showing 90% effectiveness.

The Dow popped 3% Monday while the S&P 500 ticked up 1.2% on the news.

I've been saying for some time that for the market to rise higher, we need lagging sectors like energy, banks and industrials to start pulling their weight. Those sectors have been holding everything back while tech has pushed us to record high after record high following the coronavirus crash.

Meanwhile, as the Dow and S&P were rising, the Nasdaq was falling. And now I see tech stocks consolidating and moving into a wide trading range.

I believe there's a shift going on into energy, industrials and financials, and I think that's where the action is.

Check out my appearance on Cheddar

Pfizer Vaccine News: The Truth

Behind the Company

Pfizer Inc. (NYSE: PFE) has dominated the news and Wall Street this entire week for one reason only — a potential COVID-19 vaccine.

On the night of Nov. 8, we saw the futures market gap higher and woke up the next morning to see Dow futures up over 1,000 points with news that Pfizer had a possible vaccine for COVID-19.

CEO Bourla then appeared on every news outlet imaginable, declaring that Pfizer's potential vaccine was one of the biggest medical discoveries of this century…

This quickly caused the company's stock to go on a tear, shooting up about 14%, and had Wall Street booming on the first good news in a long time.

But here's what I find especially interesting. On the same Monday morning that Pfizer unveiled its potential COVID-19 vaccine, Bourla was selling 60% of his stock at this new high.

Seems a little shady, doesn't it? If this vaccine was such a fantastic discovery, why wouldn't the CEO keep his shares? Is he so money hungry that he needed an extra $5.6 million in the bank?

Here's what I found out about Bourla's stock sell plan... and what it means for insider buyers.

Here's everything you need to know

*clicking Future of Wealth will automatically subscribe you to exclusive thefutureofwealth.com emails

It's Never Been Easier to

Get In and Cash Out

Future of Wealth Head Trader Lance Ippolito spends a lot of time talking about how to reduce risk, and during these scary market conditions… we think you understand why.

A good way to decrease risk is to simply minimize the time you spend in the market. In other words, get into a trade before a large move and quickly get out.

As a matter of fact, he's made a career out of these "24-hour trades."

You see, he deciphers data from the options market and uses it to strike moments before a stock jumps or crashes.

If you're tired of the market roller coaster and hate watching your positions plummet… we highly recommend you check out this incredible strategy.

Get in and cash out

"Your customer service and support deserves a positive 5 star review. Please send me a link if available so I can inform others that are interested in this program. Roger has been honest about everything, including the support."

Anthony

An Exponential Moving Average (EMA) is a type of moving average that places a greater weight and significance on the most recent data points. The EMA is also referred to as the exponentially weighted moving average. Exponentially weighted moving averages react more significantly to recent price changes than a Simple Moving Average (SMA).